Resverlogix Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:RFS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Nov 23	Sell€3,576	Aaron Cann	Individual	76,000	€0.047
24 Jul 23	Sell€3,769	Aaron Cann	Individual	55,000	€0.069
24 Jul 23	Sell€3,700	Aaron Cann	Individual	50,000	€0.075
06 Jul 23	Sell€6,199	Aaron Cann	Individual	90,000	€0.069
16 Jun 23	Sell€381	Aaron Cann	Individual	5,000	€0.076
15 Jun 23	Sell€3,791	Aaron Cann	Individual	50,000	€0.076
06 Jun 23	Sell€7,755	Aaron Cann	Individual	100,000	€0.08
30 May 23	Sell€2,835	Aaron Cann	Individual	34,500	€0.082

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.5%.

Top 8 shareholders own 43.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
31.1%	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	85,286,524	€3.5m	0%	no data
10.1%	Eastern Capital Limited	27,712,879	€1.1m	0%	10.83%
1.92%	Donald McCaffrey	5,263,266	€215.8k	0%	no data
0.3%	Aaron Cann	819,755	€33.6k	16.6%	no data
0.057%	Michael Sweeney	155,312	€6.4k	0%	no data
0.039%	Kenneth Zuerblis	107,062	€4.4k	0%	no data
0.038%	Kelly McNeill	105,000	€4.3k	0%	no data
0.024%	Ewelina Kulikowski	66,500	€2.7k	0%	no data